The rally attempt gained steam Tuesday. Tesla leapt late as it said an "affordable" EV is coming. Elon Musk is on the call.
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and Supply Agreement (CTCSA) with MSD (a tradename of Merck & Co., Inc., Rahway, NJ, USA).
DANVILLE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Black Hawk Acquisitions Corporation (NASDAQ: BKHAU), please note that the second paragraph reference to Mr. Ginsberg meeting "the independent director standards of The Nasdaq Stock Market" has been removed. The corrected release follows: Black Hawk Acquisition Corporation (NASDAQ: BKHAU, the "Company") announced today the appointment of Mr. Jonathan Ginsberg, age 33, to serve as a di
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|